Premium Brands (PBHN) Q3 2026 Earnings Report

The call was positive overall. Management maintained guidance, highlighted strong confirmed business and a substantial sales pipeline, reported strong year-over-year growth at Stampede despite a quarterly miss, and cited meaningful asset monetization, commodity benefits, deleveraging, and share repurchase opportunities. The main challenges were foodservice and consumer weakness, a flat EBITDA margin, Stampede's misses versus plan, delayed procurement savings, and timing uncertainty around new initiatives.

Management maintained its 2026 guidance and expects 2027 EBITDA of CAD 1 billion on a path to CAD 10 billion of sales, with organic volume growth expected to “reaccelerate to double digits next year”; sales initiatives carry contribution margins from minimal 20% to as high as 40%, but sort of in that high 20s, low 30s overall, and the CAD 800 million-CAD 900 million from next year is expected to be about 30/70, 30% run rate and 70% new initiatives, with 30%-40%, in that range for the run rate initiatives. Q4 is expected to benefit from organic volume growth, protein commodity deflation, and a 10%-10.5% EBITDA margin implied by the guidance ranges; Q4 OVGR is expected to be much better than this quarter, but it will not be as good as Q3 and is not going to be far off from that. The Stampede procurement initiative is expected to be operational in Q1 2027, with potential savings of CAD 25 million-CAD 30 million a year, immediately beneficial, and with no ramp-up associated with it; leverage is expected to reach the 3x or better target next year, with potentially mid to third quarter next year a realistic possibility, while the company remains comfortable getting to CAD 1 billion and even exceeding it in asset monetizations after realizing about CAD 250 million.